Kamada LtdNASDAQ:KMDA
- LAST PRICE5.9900
- TODAY'S CHANGE (%)0.1000 (1.6978%)
- Bid / Lots5.9300/ 16
- Ask / Lots6.0900/ 1
- Open / Previous Close5.9400 / 5.8900
- Day Range
- 52 Week Range
- Volume37,761
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KMDA |
|---|---|---|
| 09:32 ET | 3109 | 5.94 |
| 09:33 ET | 604 | 5.94 |
| 09:35 ET | 965 | 5.94 |
| 09:37 ET | 836 | 5.95 |
| 09:39 ET | 500 | 5.95 |
| 09:42 ET | 100 | 5.94 |
| 09:44 ET | 2900 | 5.95 |
| 09:46 ET | 300 | 5.95 |
| 09:48 ET | 2435 | 5.9499 |
| 09:50 ET | 2192 | 5.9499 |
| 09:51 ET | 1041 | 5.95 |
| 09:53 ET | 3604 | 5.9499 |
| 10:00 ET | 1250 | 5.94 |
| 10:02 ET | 1522 | 5.94 |
| 10:06 ET | 186 | 5.94 |
| 10:08 ET | 100 | 5.93 |
| 10:18 ET | 100 | 5.93 |
| 10:29 ET | 2010 | 5.9 |
| 10:38 ET | 100 | 5.9 |
| 10:40 ET | 180 | 5.9 |
| 11:38 ET | 1000 | 5.8505 |
| 11:50 ET | 100 | 5.86 |
| 12:03 ET | 200 | 5.87 |
| 12:10 ET | 100 | 5.87 |
| 12:17 ET | 100 | 5.86 |
| 12:24 ET | 300 | 5.86 |
| 12:26 ET | 200 | 5.85 |
| 12:50 ET | 100 | 5.86 |
| 01:00 ET | 102 | 5.85 |
| 01:31 ET | 200 | 5.84 |
| 01:38 ET | 300 | 5.87 |
| 01:44 ET | 100 | 5.875 |
| 02:09 ET | 100 | 5.86 |
| 02:18 ET | 131 | 5.85 |
| 02:23 ET | 100 | 5.86 |
| 02:27 ET | 100 | 5.85 |
| 02:34 ET | 942 | 5.9 |
| 02:50 ET | 100 | 5.935 |
| 02:59 ET | 100 | 5.92 |
| 03:08 ET | 100 | 5.9 |
| 03:30 ET | 137 | 5.9236 |
| 03:33 ET | 100 | 5.935 |
| 03:37 ET | 311 | 5.9301 |
| 03:51 ET | 100 | 5.95 |
| 03:53 ET | 660 | 5.9899 |
| 03:55 ET | 300 | 5.955 |
| 03:57 ET | 100 | 5.98 |
| 04:00 ET | 734 | 5.99 |
Nov 14, 2024
DJ Kamada Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 1:56PM ET on Thursday Nov 14, 2024 by Dow Jones
1:56PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 6, 2024
Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 4, 2024
Kamada to Present at the Stifel 2024 Healthcare Conference, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kamada Ltd | 334.0M | 19.3x | -22.48% |
Sutro Biopharma Inc | 221.8M | -1.7x | --- |
Karyopharm Therapeutics Inc | 109.8M | -1.0x | --- |
Heron Therapeutics Inc | 176.4M | -6.6x | --- |
Seres Therapeutics Inc | 149.7M | -0.8x | --- |
Arcturus Therapeutics Holdings Inc | 474.3M | -8.0x | --- |
Company Information
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Contact Information
- Headquarters
- 2 Holtzman St., Science ParkREHOVOT, Israel 7670402
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Lilach Asher Topilsky
- Chief Executive Officer
- Amir London
- Deputy Chairman of the Board
- David Tsur
- Chief Financial Officer
- Chaime Orlev
- Senior Vice President - Scientific Affairs
- Ruth Wolfson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $334.0M |
|---|---|
Revenue (TTM) | $158.4M |
Shares Outstanding | 57.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $0.31 |
Book Value | $4.25 |
P/E Ratio | 19.3x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | 11.7x |
Operating Margin | 11.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
